Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For NXGPY
Valuation Weak
14%
Profitability n.A.
Fin. Growth n.A.
Leverage & Liquidity Weak
33%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q4 Δ in %
Current Ratio 4.02 1.96 1.89
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -14.66 2.60 3.05
Naive Interpretation member
2 Per Share
Metric Q2 Q4 Δ in %
Book Value 37.83 12.49 9.06
Cash 16.28 1.61 1.39
Capex 4.86 -0.76 -0.79
Free Cash Flow 32.32 4.02 3.04
Revenue 18.84 24.57 20.68
Naive Interpretation member
3 Profitability
Metric Q2 Q4 Δ in %
Gross Margin 1.51 0.45 0.44
Operating Margin 2.54 0.18 0.17
ROA 25.87 0.10 0.08
ROE 8.93 0.32 0.29
ROIC -22.09 0.12 0.16
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of NXGPY is permitted for members.
5 Growth
The "Growth Entry" for the Focus of NXGPY is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of NXGPY is permitted for members.